PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 19346293-9 2009 Analysis of acrylamide quenching experiments revealed that the binding of metal ions to p53DBD induced a structural modification of the protein and this change provided significant protection against acrylamide quenching. Acrylamide 12-22 tumor protein p53 Homo sapiens 88-91 19346293-9 2009 Analysis of acrylamide quenching experiments revealed that the binding of metal ions to p53DBD induced a structural modification of the protein and this change provided significant protection against acrylamide quenching. Acrylamide 200-210 tumor protein p53 Homo sapiens 88-91 15240786-6 2004 RESULTS: Acrylamide and glycidamide formed DNA adducts at similar specific locations within TP53 and cII, and DNA adduct formation was more pronounced after glycidamide treatment than after acrylamide treatment at all doses tested. Acrylamide 9-19 tumor protein p53 Homo sapiens 92-96 16180010-0 2006 Involvement of the extracellular signal-regulated protein kinase pathway in phosphorylation of p53 protein and exerting cytotoxicity in human neuroblastoma cells (SH-SY5Y) exposed to acrylamide. Acrylamide 183-193 tumor protein p53 Homo sapiens 95-98 16180010-1 2006 Using human neuroblastoma SH-SY5Y cells, effects of acrylamide on p53 protein and intracellular signal transducting pathways were examined. Acrylamide 52-62 tumor protein p53 Homo sapiens 66-69 16180010-2 2006 Acrylamide increased p53, phosphorylated p53, and p53-associated protein murine double minute 2 (MDM2). Acrylamide 0-10 tumor protein p53 Homo sapiens 41-44 16180010-9 2006 Hence, acrylamide increases p53 protein and its phosphorylation at Ser15 through ERK and/or PIKK pathways. Acrylamide 7-17 tumor protein p53 Homo sapiens 28-31 32886187-0 2020 Mutagenicity of acrylamide and glycidamide in human TP53 knock-in (Hupki) mouse embryo fibroblasts. Acrylamide 16-26 tumor protein p53 Homo sapiens 52-56 32886187-7 2020 Mutations induced by glycidamide occurred at specific TP53 codons that have also been found to be mutated in human tumours (i.e., breast, ovary, colorectal, and lung) previously associated with acrylamide exposure. Acrylamide 194-204 tumor protein p53 Homo sapiens 54-58